Shares of Virios Therapeutics, Inc. (NASDAQ:VIRI – Get Free Report) rose 3.1% during trading on Monday . The company traded as high as $1.8050 and last traded at $1.8050. 6,746 shares were traded during mid-day trading, a decline of 99% from the average session volume of 1,049,645 shares. The stock had previously closed at $1.75.
Virios Therapeutics Stock Up 0.5%
The firm has a market capitalization of $35.43 million, a P/E ratio of -6.81 and a beta of 1.58. The business has a 50-day moving average price of $1.54 and a 200-day moving average price of $2.08.
About Virios Therapeutics
Virios Therapeutics, Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted therapies for fibrotic diseases. The company leverages its proprietary small-molecule platform to identify and advance compounds designed to modulate key pathways involved in scar formation and tissue repair. By concentrating on conditions with high unmet medical need, Virios aims to improve patient outcomes through more effective and safer treatment options.
The company’s lead development candidate, VTI-1002, is an oral small molecule inhibitor in clinical trials for the prevention and treatment of hypertrophic scars and keloids.
See Also
- Five stocks we like better than Virios Therapeutics
- GE Vernova’s AI Power Boom Faces a Profit Test
- Cardinal Health Earnings: Can Perfection Get Priced In Twice?
- Nebius’ Q2 Beat Shows the AI Bottleneck Is Capacity, Not Demand
- Legacy Jet Builders Stall While Embraer Accelerates to New Highs
Receive News & Ratings for Virios Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Virios Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
